Project Number 5R01AG055784-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Characterizing the roles of novel soluble GSMs in AD pathology. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator ZHANG, CAN MARTIN Principal Investigator First Name CAN MARTIN Principal Investigator Last Name ZHANG Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-160: NIH Research Project Grant (Parent R01) FY Overall Cost $425,945 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
